666

GEMPHARMATECH

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
Revenue estimate
Market capitalization
‪3.75 B‬CNY
‪158.95 M‬CNY
‪622.19 M‬CNY
‪18.84 M‬
Beta (1Y)
1.35

About GEMPHARMATECH

CEO
Jing Zhao
Headquarters
Nanjing
Founded
2017
ISIN
CNE100005964
FIGI
BBG011YS3HQ8
GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. Its services include custom model generation, cell lines and customization, germ-gree and microbiome, preclinical testing, custom breeding, animal quality testing services. The company was founded by Xiang Gao on December 29, 2017 and is headquartered in Nanjing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688046 is 12.72 CNY — it has decreased by 2.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GEMPHARMATECH stocks are traded under the ticker 688046.
GEMPHARMATECH is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
688046 stock is 3.99% volatile and has beta coefficient of 1.35. Check out the list of the most volatile stocks — is GEMPHARMATECH there?
GEMPHARMATECH revenue for the last quarter amounts to ‪168.00 M‬ CNY despite the estimated figure of ‪168.00 M‬ CNY. In the next quarter revenue is expected to reach ‪154.00 M‬ CNY.
Yes, you can track GEMPHARMATECH financials in yearly and quarterly reports right on TradingView.
688046 stock has risen by 12.57% compared to the previous week, the month change is a 2.45% fall, over the last year GEMPHARMATECH has showed a 42.78% decrease.
688046 net income for the last quarter is ‪41.24 M‬ CNY, while the quarter before that showed ‪40.15 M‬ CNY of net income which accounts for 2.72% change. Track more GEMPHARMATECH financial stats to get the full picture.
Yes, 688046 dividends are paid annually. The last dividend per share was 0.04 CNY. As of today, Dividend Yield (TTM)% is 0.31%. Tracking GEMPHARMATECH dividends might help you take more informed decisions.
Like other stocks, 688046 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GEMPHARMATECH stock right from TradingView charts — choose your broker and connect to your account.
688046 reached its all-time high on Aug 23, 2022 with the price of 35.87 CNY, and its all-time low was 10.10 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GEMPHARMATECH technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GEMPHARMATECH stock shows the neutral signal. See more of GEMPHARMATECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GEMPHARMATECH future price: according to them, 688046 price has a max estimate of 26.77 CNY and a min estimate of 16.63 CNY. Read a more detailed GEMPHARMATECH forecast: see what analysts think of GEMPHARMATECH and suggest that you do with its stocks.